• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿昔洛韦在豚鼠、兔和猴体内的代谢情况。

Metabolic disposition of acyclovir in the guinea pig, rabbit, and monkey.

作者信息

Good S S, de Miranda P

出版信息

Am J Med. 1982 Jul 20;73(1A):91-5. doi: 10.1016/0002-9343(82)90071-7.

DOI:10.1016/0002-9343(82)90071-7
PMID:7102713
Abstract

Two guinea pigs and two rabbits were each inoculated subcutaneously with 14C-labeled acyclovir (25 mg/kg). Both species excreted the entire amount within 72 hours. The rabbits excreted all of the radioactivity in the urine while the guinea pigs excreted an average of 14.2 percent in the feces. The rabbits excreted an average of 71.0 percent of the dose as unchanged drug; 25.1 percent was excreted as 9-carboxymethoxymethylguanine (CMMG) and 3.5 percent as 8-hydroxy-9-(2-hydroxyethoxymethyl)guanine (8-hydroxyacyclovir). An average of 60.7 percent of the dose was recovered from the guinea pigs as acyclovir; 32.3 percent was excreted as CMMG and 3.1 percent as 8-hydroxyacyclovir. The two rabbits showed elimination-phase half-lives (t 1/2 beta) for plasma acyclovir of 0.8 and 2.2 hours. Mean t 1/2 beta for acyclovir in two rhesus, four patas, and four african green monkeys, each receiving acyclovir (10 mg/kg) as a bolus intravenous injection, were 1.2, 1.7, and 1.8 hours respectively. The average 48 hour urinary excretion of acyclovir, 8-hydroxyacyclovir, and CMMG in the rhesus monkey was estimated to be 21.3 percent, 15.3 percent, and 7.1 percent, respectively, of the total administered amount. The patas and african green species excreted the dose mostly as acyclovir and CMMG.

摘要

给两只豚鼠和两只兔子分别皮下注射14C标记的阿昔洛韦(25毫克/千克)。两种动物均在72小时内排出全部剂量。兔子将所有放射性物质经尿液排出,而豚鼠平均有14.2%经粪便排出。兔子平均以原形药物排出剂量的71.0%;25.1%以9-羧甲氧基甲基鸟嘌呤(CMMG)形式排出,3.5%以8-羟基-9-(2-羟基乙氧基甲基)鸟嘌呤(8-羟基阿昔洛韦)形式排出。豚鼠平均有60.7%的剂量以阿昔洛韦形式回收;32.3%以CMMG形式排出,3.1%以8-羟基阿昔洛韦形式排出。两只兔子血浆中阿昔洛韦的消除相半衰期(t 1/2β)分别为0.8小时和2.2小时。两只恒河猴、四只粗尾猴和四只非洲绿猴,每只均接受阿昔洛韦(10毫克/千克)静脉推注,阿昔洛韦的平均t 1/2β分别为1.2小时、1.7小时和1.8小时。恒河猴48小时内阿昔洛韦、8-羟基阿昔洛韦和CMMG的平均尿排泄量估计分别为总给药量的21.3%、15.3%和7.1%。粗尾猴和非洲绿猴这两个物种排出的剂量大多为阿昔洛韦和CMMG。

相似文献

1
Metabolic disposition of acyclovir in the guinea pig, rabbit, and monkey.阿昔洛韦在豚鼠、兔和猴体内的代谢情况。
Am J Med. 1982 Jul 20;73(1A):91-5. doi: 10.1016/0002-9343(82)90071-7.
2
Species differences in the disposition of acyclovir.阿昔洛韦处置过程中的种属差异。
Am J Med. 1982 Jul 20;73(1A):31-5. doi: 10.1016/0002-9343(82)90059-6.
3
Metabolic fate of radioactive acyclovir in humans.放射性阿昔洛韦在人体内的代谢命运。
Am J Med. 1982 Jul 20;73(1A):215-20. doi: 10.1016/0002-9343(82)90094-8.
4
The disposition of acyclovir in different species.阿昔洛韦在不同物种中的处置情况。
J Pharmacol Exp Ther. 1981 Nov;219(2):309-15.
5
Disposition of intravenous radioactive acyclovir.静脉注射放射性阿昔洛韦的处置
Clin Pharmacol Ther. 1981 Nov;30(5):662-72. doi: 10.1038/clpt.1981.218.
6
Acyclovir treatment of experimental simian varicella infection of monkeys.阿昔洛韦治疗猴实验性猿猴水痘感染
Antimicrob Agents Chemother. 1981 Sep;20(3):291-7. doi: 10.1128/AAC.20.3.291.
7
The disposition of a novel tetrahydroquinoline, tiquinamide, in rats and patas monkeys.
Eur J Drug Metab Pharmacokinet. 1982;7(3):173-82. doi: 10.1007/BF03189563.
8
Acyclovir kinetics after intravenous infusion.静脉输注后阿昔洛韦的动力学
Clin Pharmacol Ther. 1979 Dec;26(6):718-28. doi: 10.1002/cpt1979266718.
9
Metabolic fate and pharmacokinetics of the acyclovir prodrug valaciclovir in cynomolgus monkeys.阿昔洛韦前体药物伐昔洛韦在食蟹猴体内的代谢命运和药代动力学
Drug Metab Dispos. 1994 Jan-Feb;22(1):55-9.
10
High serum concentrations of the acyclovir main metabolite 9-carboxymethoxymethylguanine in renal failure patients with acyclovir-related neuropsychiatric side effects: an observational study.肾功能衰竭患者出现阿昔洛韦相关神经精神副作用时血清中阿昔洛韦主要代谢产物9-羧甲氧基甲基鸟嘌呤的高浓度:一项观察性研究。
Nephrol Dial Transplant. 2003 Jun;18(6):1135-41. doi: 10.1093/ndt/gfg119.

引用本文的文献

1
Examination of Urinary Excretion of Unchanged Drug in Humans and Preclinical Animal Models: Increasing the Predictability of Poor Metabolism in Humans.人体和临床前动物模型中未变化药物的尿排泄检查:提高人类代谢不良的预测性。
Pharm Res. 2021 Jul;38(7):1139-1156. doi: 10.1007/s11095-021-03076-y. Epub 2021 Jul 12.
2
Absorption, Distribution, Metabolism, and Excretion of the Novel Helicase-Primase Inhibitor, Amenamevir (ASP2151), in Rodents.新型解旋酶-引发酶抑制剂阿美那韦(ASP2151)在啮齿动物体内的吸收、分布、代谢和排泄
Eur J Drug Metab Pharmacokinet. 2018 Dec;43(6):693-706. doi: 10.1007/s13318-018-0481-y.
3
Vitreous pharmacokinetics and electroretinographic findings after intravitreal injection of acyclovir in rabbits.
兔眼玻璃体内注射阿昔洛韦后的药代动力学和视网膜电流图研究。
Clinics (Sao Paulo). 2012 Aug;67(8):931-7. doi: 10.6061/clinics/2012(08)13.
4
Nobel lecture in physiology or medicine--1988. The purine path to chemotherapy.1988年诺贝尔生理学或医学奖演讲。嘌呤类化疗药物的研发历程
In Vitro Cell Dev Biol. 1989 Apr;25(4):321-30. doi: 10.1007/BF02624593.